Details for New Drug Application (NDA): 020938
✉ Email this page to a colleague
NDA 020938 describes MOBIC, which is a drug marketed by Boehringer Ingelheim and is included in one NDA. Additional details are available on the MOBIC profile page.
The generic ingredient in MOBIC is meloxicam. There are twenty-two drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the meloxicam profile page.
The generic ingredient in MOBIC is meloxicam. There are twenty-two drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the meloxicam profile page.
Summary for 020938
| Tradename: | MOBIC |
| Applicant: | Boehringer Ingelheim |
| Ingredient: | meloxicam |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 7.5MG | ||||
| Approval Date: | Apr 13, 2000 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 15MG | ||||
| Approval Date: | Aug 23, 2000 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
